期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Deciphering the roles of neddylation modification in hepatocellular carcinoma:Molecular mechanisms and targeted therapeutics
1
作者 Wenxin Wu Xuanyi Wang +3 位作者 Ruijie Ma Shuhong Huang Hongguang Li xinxing lyu 《Genes & Diseases》 2025年第4期342-357,共16页
Hepatocellular carcinoma(HCC)is the most prevalent type of malignant liver tu-mor with high morbidity and mortality and severely threatens human health and life quality.Thus,it is of great significance to investigate ... Hepatocellular carcinoma(HCC)is the most prevalent type of malignant liver tu-mor with high morbidity and mortality and severely threatens human health and life quality.Thus,it is of great significance to investigate the molecular mechanism underlying the patho-genesis of HCC and seek biomarkers for early diagnosis.Neddylation,one of the most conserved post-translational modification types in eukaryotes,plays vital roles in the progres-sion of HCC.During the process of neddylation,NEDD8 is covalently conjugated to its substrate proteins,thereby modulating multiple necessary biological processes.Currently,increasing ev-idence shows that the aberrant activation of neddylation is positively correlated with the occurrence and development of tumors and the poor clinical prognosis of HCC patients.Based on the current investigations,neddylation modification has been reported to target both the cullins and non-cullin substrates and subsequently affect HCC progression,including the virus infection,malignant transformation,tumor cell proliferation,migration and invasion ability,and tumor microenvironment.Therefore,inhibitors targeting the neddylation cascade have been developed and entered clinical trials,indicating satisfactory anti-HCC treatment effects.This review aims to summarize the latest progress in the molecular mechanism of pathologi-cally aberrant neddylation in HCC,as well as the advances of neddylation-targeted inhibitors as potential drugs for HCC treatment. 展开更多
关键词 Cancer therapy Hepatocellular carcinoma NEDDYLATION Post-translation modification Targeted inhibitors
原文传递
Coactivator-associated arginine methyltransferase 1: A versatile player in cell differentiation and development 被引量:1
2
作者 Zhongrui Ma xinxing lyu +5 位作者 Ning Qin Haoyu Liu Mengrui Zhang Yongchao Lai Bo Dong Peiyuan Lu 《Genes & Diseases》 SCIE CSCD 2023年第6期2383-2392,共10页
Protein arginine methylation is a common post-translational modification involved in the regulation of various cellular functions. Coactivator-associated arginine methyltransferase 1 (CARM1) is a protein arginine meth... Protein arginine methylation is a common post-translational modification involved in the regulation of various cellular functions. Coactivator-associated arginine methyltransferase 1 (CARM1) is a protein arginine methyltransferase that asymmetrically dimethylates histone H3 and non-histone proteins to regulate gene transcription. CARM1 has been found to play important roles in cell differentiation and development, cell cycle progression, autophagy, metabolism, pre-mRNA splicing and transportation, and DNA replication. In this review, we describe the molecular characteristics of CARM1 and summarize its roles in the regulation of cell differentiation and development in mammals. 展开更多
关键词 Arginine methylation CARM1 Cell differentiation DEVELOPMENT Epigenetic regulation
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部